| 111 |
Multidisciplinary decision making in the management of
hepatocellular carcinoma: A hospital-based study |
2015 |
| 112 |
Multidisciplinary decision making in the management of
hepatocellular carcinoma: A hospital-based study |
2015 |
| 113 |
Noninvasive assessment of liver fibrosis in hepatitis C: acoustic radiation force impulse imaging (shear wave elastography) and liver fibrosis biomarkers versus liver biopsy |
2015 |
| 114 |
Noscocomial respiratory tract infection in patients with liver cirrhosis |
2015 |
| 115 |
Noscocomial respiratory tract infection in patients with liver cirrhosis |
2015 |
| 116 |
Noscocomial respiratory tract infection in patients with liver cirrhosis |
2015 |
| 117 |
Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate |
2015 |
| 118 |
The role of Fibroscan in predicting the presence of varices in patients with cirrhosis |
2015 |
| 119 |
Is FoxP3 a good marker for regulatory T Cells?. |
2014 |
| 120 |
Serum profiles of extracellular matrix degradation inhibitors across the stages of liver fibrosis in chronic hepatitis C patients. Assiut Med.J |
2014 |
هل لديك سؤال ؟
